High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 401–500 of 865
Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia
Furuyama, K., & Kaneko, K. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2368-0 · Cited by 30
“found that the serum concentration of growth differentiation factor 15 (GDF15), a member of the transforming growth factor β superfamily, was increased in thalassemia patients compared with that in normal volunteers, and GDF15 could suppress hepcidin expression in the liver [81].”
BackgroundA systems biology pipeline identifies regulatory networks for stem cell engineering
Kinney, M. A., Vo, L. T., Frame, J. M., Barragan, J., Conway, A. J., Li, S., Wong, K., Collins, J. J., Cahan, P., North, T. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0159-2 · Cited by 28
Mazgaj, R., Lipiński, P., Edison, E. S., Bednarz, A., Staroń, R., Haberkiewicz, O., Lenartowicz, M., Smuda, E., Jończy, A., & Starzyński, R. R. (2021) · American Journal of Hematology · doi:10.1002/ajh.26152 · Cited by 30
“Similarly, in the bone marrow cells of these animals we detected increased expression of GDF15, another inhibitor of hepcidin expression, originally reported to be secreted at high levels during erythroblast maturation.(29) Thus, our results suggest that the inhibition of maternal hepcidin in pregnancy is mediated by…”
BackgroundCirculating factors are involved in hypoxia-induced hepcidin suppression
Ravasi, G., Pelucchi, S., Greni, F., Mariani, R., Giuliano, A., Parati, G., Silvestri, L., & Piperno, A. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.06.006 · Cited by 29
“GDF-15 and TWSG1 have been previously proposed as candidate erythroid regulators of hepcidin based on findings in patients affected by severe ineffective erythropoiesis [17,18], but recently, Casanovas et al.”
BackgroundIron and erythropoiesis: a dual relationship
Camaschella, C., & Pagani, A. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0743-1 · Cited by 29
“GDF15 is a cytokine produced by mature erythroblasts with an in vitro partial inhibitory activity on hepcidin transcription in hepatoma cells and primary hepatocytes, but only at very high doses [ 51 ].”
BackgroundProtein antioxidants in thalassemia.
Awadallah, S. (2013) · Advances in Clinical Chemistry · doi:10.1016/b978-0-12-407681-5.00003-9 · Cited by 21
Chen, H., Choesang, T., Li, H., Sun, S., Pham, P., Bao, W., Feola, M., Westerman, M., Li, G., Follenzi, A., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.127902 · Cited by 26
Wang, C., Fang, Z., Zhu, Z., Liu, J., & Chen, H. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.05.002 · Cited by 30
Effectiveness of deferiprone in transfusion‐independent beta‐thalassemia/HbE patients
Akrawinthawong, K., Chaowalit, N., Chatuparisuth, T., & Siritanaratkul, N. (2011) · Hematology · doi:10.1179/102453311x12940641877768 · Cited by 26
The Pathology of Comparative Animal Models of Human Haemochromatosis
Klopfleisch, R., & Olias, P. (2012) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2012.09.001 · Cited by 28
“Matriptase-2 appears to cause proteolysis of members of these positive regulators of hepcidin expression, while the mechanisms of hepcidin inhibition by GDF15 and HIF1a are unknown (Peyssonnaux et al., 2007; Tanno et al., 2007; Du et al., 2008).”
BackgroundAmbachew, S., & Biadgo, B. (2017) · Acta Haematologica · doi:10.1159/000481391 · Cited by 27
Iron overload and allogeneic hematopoietic stem-cell transplantation
Kanda, J., Kawabata, H., & Chao, N. J. A. (2011) · Expert Review of Hematology · doi:10.1586/ehm.10.81 · Cited by 28
Lainé, F., Laviolle, B., Ropert, M., Bouguen, G., Morçet, J., Hamon, C., Massart, C., Westermann, M., Deugnier, Y., & Loréal, O. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2097-7 · Cited by 26
Tarkun, P., Mehtap, Ö., Ateşoğlu, E. B., Gedük, A., Musul, M. M., & Hacıhanefioğlu, A. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12150 · Cited by 29
“It has been demonstrated that GDF-15 protein suppresses hepcidin secretion and that very high levels of GDF-15 are required for this suppression (10, 11).”
BackgroundInfluentialRecent advances in iron metabolism and related disorders
Camaschella, C., & Strati, P. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0387-4 · Cited by 31
“In these cases, increased iron absorption has been ascribed to hepcidin suppression by the increased erythroid production of growth differentiation factor 15 (GDF15), a member of TGF-beta superfamily, which at high concentration may suppress hepcidin mRNA expression [7].”
BackgroundRana, S., & Prabhakar, N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.032 · Cited by 26
Biomarkers Utility: At the Borderline between Cardiology and Neurology
Chetran, A., Stafie, C. S., Mitu, O., Ciobanu, E. C., Iliescu-Halițchi, D., Costache, A. D., Bobric, C., Troase, R., Mitu, I., Huzum, B., et al. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110139 · Cited by 31
Małyszko, J., Małyszko, J. S., & Myśliwiec, M. (2009) · Renal Failure · doi:10.1080/08860220903082606 · Cited by 27
Evaluating the Safety and Efficacy of Silymarin in β -Thalassemia Patients: A Review
Esfahani, B. A.-S. M., Reisi, N., & Mirmoghtadaei, M. (2015) · Hemoglobin · doi:10.3109/03630269.2014.1003224 · Cited by 25
“, growth differentiating factor 15), that in turn reduces the iron regulatory protein hepcidin production (15), leading to upregulation of ferroproteins on the surface of absorptive enterocytes and thereby increasing iron absorption (16).”
BackgroundRobach, P., Recalcati, S., Girelli, D., Campostrini, N., Kempf, T., Wollert, K. C., Corbella, M., Santambrogio, P., Perbellini, L., Brasse‐Lagnel, C., et al. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12122 · Cited by 25
“Although we serially quantified the response of four potential hepcidin regulators (sTfR, iron saturation of transferrin, GDF-15, and soluble HJV) as well as skeletal muscle factors thought to be involved in soluble HJV release, we could not identify any factor clearly accounting for the hepcidin down-modulation.”
BackgroundInfluentialLarissi, K., Politou, M., Margeli, A. P., Poziopoulos, C., Flevari, P., Terpos, E., Papassotiriou, I., & Voskaridou, E. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.04.011 · Cited by 25
The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis
Uchiyama, T., Kawabata, H., Miura, Y., Yoshioka, S., Iwasa, M., Yao, H., Sakamoto, S., Fujimoto, M., Haga, H., Kadowaki, N., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.502 · Cited by 25
“Common features of these diseases include systemic iron overload and ineffective erythropoiesis, and the major source of the serum GDF15 in these diseases is assumed to be erythroid cells [14].”
BackgroundHong, J. H., Choi, Y., Min, B.-K., Park, K. S., Seong, K., Lee, I. K., & Kim, J. G. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.001 · Cited by 25
“, higher levels of GDF15 suppressed the expression of hepcidin in thalassemia patients [30].”
BackgroundManagement of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Brissot, É., Savani, B. N., & Mohty, M. (2012) · Seminars in Hematology · doi:10.1053/j.seminhematol.2011.10.003 · Cited by 24
van Eijk, L. T., Heemskerk, S., van der Pluijm, R. W., van Wijk, S. M., Peters, W. H. M., van der Hoeven, J. G., Kox, M., Swinkels, D. W., & Pickkers, P. (2013) · Haematologica · doi:10.3324/haematol.2013.088047 · Cited by 24
GDF15 Is Related to Anemia and Hepcidin in Kidney Allograft Recipients
Małyszko, J., Koc‐Żórawska, E., Małyszko, J. S., Głowińska, I., Myśliwiec, M., & Macdougall, I. C. (2013) · Nephron Clinical Practice · doi:10.1159/000351810 · Cited by 24
Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment
Li, H., Lodish, H. F., & Sieff, C. A. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.005 · Cited by 25
Park, S., Kosmider, O., Maloisel, F., Drénou, B., Chapuis, N., Lefèbvre, T., Karim, Z., Puy, H., Alary, A., Ducamp, S., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.203158 · Cited by 26
“Interestingly, ineffective erythropoiesis has been correlated with high levels of serum growth differentiation factor-15 (GDF-15), a member of the transforming growth factor-b superfamily that is produced by erythroid precursors at the end of the differentiation process.(15,16) Upon chronic RBC transfusions, patients…”
Hepcidin in chronic kidney disease anemia
Santos‐Silva, A., Ribeiro, S., Reis, F., & Belo, L. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.012 · Cited by 30
Jenkitkasemwong, S., Broderius, M. A., Nam, H., Prohaska, J. R., & Knutson, M. D. (2010) · Journal of Nutrition · doi:10.3945/jn.109.117077 · Cited by 25
“In addition to TfR2-associated downregulation of hepcidin synthesis, erythroid-derived signaling molecules that are released during states of enhanced erythropoiesis (41,42) may independently contribute to the hepcidin suppression in anemic Trf mice and CuD rats.”
BackgroundInherited metabolic disease of the liver
Pietrangelo, A. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328329e13d · Cited by 27
A Strong Anti-Inflammatory Signature Revealed by Liver Transcription Profiling of Tmprss6-/- Mice
Riba, M., Rausa, M., Sorosina, M., Cittaro, D., Garcia Manteiga, J. M., Nai, A., Pagani, A., Martinelli-Boneschi, F., Stupka, E., Camaschella, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069694 · Cited by 23
“Gdf15 has been proposed also as a hepcidin inhibitor [34].”
BackgroundRey, M. D., Benito, R., Fontanillo, C., Campos-Laborie, F. J., Janusz, K., Velasco-Hernández, T., Abáigar, M., Hernández‐Sánchez, M., Cuello, R., Borrego, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126555 · Cited by 23
“In addition, it has been suggested that over-expression of GDF15 in patients with RARS might be involved in the systemic iron overload by suppressing hepcidin secretion [43,44], being sensitive to iron depletion and this response is specifically antagonized by the reprovision of iron [45].”
Yuan, Z., Li, H., Qi, Q., Gong, W., Qian, C., Dong, R., Zang, Y., Li, J., Zhou, M., Cai, J., et al. (2016) · Scientific Reports · doi:10.1038/srep28221 · Cited by 23
Hepcidin regulation in a mouse model of acute hypoxia
Ravasi, G., Pelucchi, S., Comani, G. B., Greni, F., Mariani, R., Pelloni, I., Bombelli, S., Perego, R., Barisani, D., & Piperno, A. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13062 · Cited by 24
Signaling pathways regulating hepcidin
Rishi, G., & Subramaniam, V. N. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.003 · Cited by 24
Fang, Z., Zhu, Z., Zhang, H., Peng, Y., Liu, J., Lu, H., Jiang, L., Liang, L., Xia, S., Wang, Q., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16156 · Cited by 25
Shokrgozar, N., Amirian, N., Ranjbaran, R., Bazrafshan, A., & Sharifzadeh, S. (2020) · Annals of Hematology · doi:10.1007/s00277-020-03931-9 · Cited by 24
Iron Metabolism, Iron Deficiency and Disorders of Haem Synthesis
Hoffbrand, A. V., Hershko, C., & Camaschella, C. (2010) · Wiley eBooks · doi:10.1002/9781444323160.ch3 · Cited by 25
Future alternative therapies for β-thalassemia
Rivella, S., & Rachmilewitz, E. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.56 · Cited by 29
Govus, A. D., Abbiss, C. R., Garvican-Lewis, L. A., Swinkels, D. W., Laarakkers, C. M., Gore, C. J., & Peeling, P. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2938-2 · Cited by 22
“…an increase in serum erythropoietin (EPO) concentration (robach et al. 2009, 2013), and an up-regulation of growth differentiation factor-15 (gDF-15) (tanno et al. 2007) or tWSg1 (tanno et al. 2009) may also suppress hepcidin expression. reduced hepcidin activity in hypoxic conditions enhances…”
BackgroundSaad, H. K. M., Rahman, A. A. A., Ghani, A. S. A., Taib, W. R. W., Ismail, I., Johan, M. F., Al-wajeeh, A. S., & Al‐Jamal, H. A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10010189 · Cited by 29
“The decreased serum hepcidin levels in β-thalassemia patients are associated with the downregulation of hepcidin expression in liver cells, resulting in continuous absorption of dietary iron that leads to iron overload [58].”
BackgroundWhat regulates hepcidin in poly-transfused β-Thalassemia Major: Erythroid drive or store drive?
Chauhan, R., Sharma, S., & Chandra, J. (2014) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.130891 · Cited by 25
Jang, J. H., Kim, Y., Park, S., Kım, K., Kim, S. J., Kim, W. S., Jung, C. W., Lee, J., & Lee, S. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003091 · Cited by 22
“Erythropoietic stimulators [33] and hypoxia [34] also negatively regulate hepcidin, increasing iron availability for erythropoiesis [35].”
BackgroundXu, W., Zhou, B., Wu, J., Jiang, P., Chen, H., & Yan, F. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46261 · Cited by 22
“the expression level of the iron regulatory protein hepcidin [45], cancer cachexia [21], and SMAD protein activation in the myocardium [23].”
BackgroundHaemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118853771.ch6 · Cited by 28
Actualité du métabolisme du fer
Beaumont, C., & Karim, Z. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.04.006 · Cited by 39
Pathophysiology of perioperative anaemia
Singh, S. P., Gudzenko, V., & Fink, M. P. (2012) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2012.11.002 · Cited by 25
Iron metabolism and ineffective erythropoiesis in β‐thalassemia mouse models
Ramos, P., Melchiori, L., Gardenghi, S., Van‐Roijen, N., Grady, R. W., Ginzburg, Y., & Rivella, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05596.x · Cited by 20
Molecular Mechanisms of Intestinal Iron Transport
Collins, J. F., & Anderson, G. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00071-3 · Cited by 24
Hematologic Aspects of Kidney Disease
Brugnara, C., & Eckardt, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10056-9 · Cited by 26
Tantawy, A. A. G., Adly, A. A. M., Ismail, E. A. R., Youssef, O. I., & Ali, M. E. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.06.001 · Cited by 22
“[12] have reported that in patients with β-thalassemia, serum GDF-15 levels are elevated, which results in the suppression of the iron regulatory protein hepcidin [12,29].”
BackgroundInfluentialTamez, P. A., Liu, H., Wickrema, A., & Haldar, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019307 · Cited by 21
“GDF15 is thought to contribute to iron overloading, a correlate of ineffective erythropoiesis, by preventing hepcidin expression and thereby increasing iron absorption [24].”
BackgroundLiu, S., Suragani, R. N. V. S., Han, A., Zhao, W., Andrews, N. C., & Chen, J.-J. (2008) · Haematologica · doi:10.3324/haematol.12175 · Cited by 22
“Interestingly, the serum level of growth differentiation factor (GDF),(15) which is a member of TGF-β superfamily, was found to be elevated in β-thalassemic patients.(22) Expression of GDF15 was increased during”
BackgroundInfluentialYuki, K. E., Eva, M. M., Richer, E., Chung, D., Paquet, M., Cellier, M., Canonne-Hergaux, F., Vaulont, S., Vidal, S. M., & Malo, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055331 · Cited by 20
“GDF15 is a member of the TGFb superfamily that was shown to negatively regulate the expression of Hamp in vitro [45,46].”
Santhakumar, S., Aaron, R., Cherian, A. G., Abraham, V. J., George, B., Lipiński, P., & Edison, E. S. (2023) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102727 · Cited by 28
Effect of Iron Overload and Iron Deficiency on Liver Hemojuvelin Protein
Krijt, J., Frýdlová, J., Kukačková, L., Fujikura, Y., Přikryl, P., Vokurka, M., & Nečas, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037391 · Cited by 24
“Several candidates for the molecules linking accelerated erythropoiesis in the bone marrow and spleen with liver Hamp gene expression have been proposed [39], but their role is probably restricted to pathological conditions such as thalassemias [40].”
BackgroundMillot, S., Delaby, C., Moulouel, B., Lefèbvre, T., Pilard, N., Ducrot, N., Ged, C., Lettéron, P., Franceschi, L. D., Deybach, J. C., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.151621 · Cited by 21
“Since low hepcidin levels favor intestinal iron absorption and mobilization of tissue iron stores, its repression accounts for the paradoxical condition known as iron loading anemia.(4,5) In hemolytic anemia, much less is known about hepcidin expression and the pattern of iron loading compared to anemia with ineffecti…”
BackgroundAlphavirus Nonstructural Proteases and Their Inhibitors
Bissoyi, A., Pattanayak, S. K., Bit, A., Patel, A. K., Singh, A. K., Behera, S. S., & Satpathy, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809712-0.00004-6 · Cited by 22
“4.5 represents the last catalytic subunit of Alphavirus that acts as RNA-dependent RNA polymerase (RdRP) (Hahn et al., 1989; Tanno et al., 2007).”
BackgroundInfluentialHuang, Y., Liu, R., Wei, X., Liu, J., Pan, L., Yang, G., & Lai, Y. (2019) · BioMed Research International · doi:10.1155/2019/4504302 · Cited by 22
“These data suggest that excessive release of GFD15 may suppress hepcidin production and thus dysregulate iron homeostasis in thalassemia syndromes [18, 20].”
BackgroundInfluentialHepcidin and Its Role in Iron Homeostasis.
Kwapisz, J., Słomka, A., & Żekanowska, E. (2009) · PubMed Central · Cited by 36
Ponka, P., Tenenbein, M., & Eaton, J. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-59453-2.00041-x · Cited by 20
Iron deficiency anaemia and iron overload
Worwood, M., & May, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3408-4.00009-6 · Cited by 20
GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
Yalçın, M. M., Altınova, A. E., Aktürk, M., Gülbahar, Ö., Arslan, E., Şendoğan, D. Ö., Yetkin, İ., & Törüner, F. B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1240843 · Cited by 21
Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
Adolph, T. E., Grabherr, F., Mayr, L., Grander, C., Enrich, B., Moschen, A. R., & Tilg, H. (2018) · Journal of Obesity · doi:10.1155/2018/7108075 · Cited by 21
“Moreover, GDF15 controls hepatic hepcidin expression and iron overload which may set the susceptibility to NAFLD [25, 26].”
BackgroundZhu, Y., Li, X., Chang, C., Xu, F., He, Q., Guo, J., Tao, Y., Liu, Y., Liu, L., & Shi, W. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.02.011 · Cited by 19
“The expression of GDF-15 is at low levels during normal erythropoiesis, but at high levels in patients with ineffective erythropoiesis [25,26].”
BackgroundMałyszko, J., Koc‐Żórawska, E., Levin-Iaina, N., Małyszko, J. S., Koźmiński, P., Kobus, G., & Myśliwiec, M. (2012) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1458 · Cited by 22
Sîrvent, A., Auquier, P., Oudin, C., Bertrand, Y., Bohrer, S., Chastagner, P. B., Poirée, M., Kanold, J., Thouvenin, S., Pérel, Y., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.205 · Cited by 19
Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease
Ginzburg, Y. Z. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.03.001 · Cited by 20
Increased hepcidin levels in high-altitude pulmonary edema
Altamura, S., Bärtsch, P., Dehnert, C., Maggiorini, M., Weiß, G., Theurl, I., Muckenthaler, M. U., & Mairbäurl, H. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00940.2014 · Cited by 19
“Elevated levels of growth differentiation factor-15 (GDF-15) (28), twisted gastrulation (TWSG1) (29), and the platelet-derived growth factor (PDGF) (24) have been suggested as circulating factors decreasing hepcidin expression.”
BackgroundTony, S., Daar, S., Elshinawy, M., Al-Zadjaly, S., Al-Khabori, M. K., & Wali, Y. A. M. S. (2012) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2012.708891 · Cited by 19
“Another possible explanation suggests the roles of growth differentiation factor 15 (GDF 15) and twisted gastrulation (TWSG1) cytokine, as both were shown to downregulate hepcidin expression in animal models [23, 24].”
BackgroundSuppression of plasma hepcidin by venesection during steady-state hypoxia
Talbot, N. P., Smith, T. G., Lakhal‐Littleton, S., Gülsever, C. İ., Rivera, M. C., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2016) · Blood · doi:10.1182/blood-2015-05-647404 · Cited by 20
Tackling the unknowns in understanding and management of hospital acquired anemia
Bressman, E., Jhang, J. S., McClaskey, J. H., & Ginzburg, Y. Z. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100830 · Cited by 19
Fujiwara, T., Ikeda, T., Nagasaka, Y., Okitsu, Y., Katsuoka, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., Ichinohasama, R., Tomosugi, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075568 · Cited by 18
“Beyond the regulation of Gdf15 in hepatocytes, erythroid cells have also been suggested to be one of the main sources of GDF15, especially in conditions associated with inefficient erythropoiesis, such as thalassemia [19].”
BackgroundInfluentialSerum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients
Tarkun, P., Ateşoğlu, E. B., Mehtap, Ö., Musul, M. M., & Hacıhanefioğlu, A. (2013) · Acta Haematologica · doi:10.1159/000354835 · Cited by 18
Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice
Krijt, J., Jonasova, A. T., Neuwirtová, R., & Nečas, E. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.012 · Cited by 19
Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis
Rybińska, I., & Cairo, G. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.01.001 · Cited by 18
Chen, Y., Liu, D., Zhao, Y., Wang, H.-T., Gao, Y., & Chen, Y. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2237 · Cited by 18
“In contrast, intense cellular stress and inflammation and genetic mutations also enhance MIC-1 expression and aberrant activation of the MIC-1-mediated signaling cascades, which might contribute to cancer progression (Tanno et al. , 2007; Boyle et al. , 2009).”
RetractedHaemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2010) · Wiley eBooks · doi:10.1002/9781444323160.ch6 · Cited by 21
Sakamoto, S., Kawabata, H., Kanda, J., Uchiyama, T., Mizumoto, C., Kitano, T., Kondo, T., Hishizawa, M., Tomosugi, N., & Takaori‐Kondo, A. (2016) · Cancer Medicine · doi:10.1002/cam4.974 · Cited by 18
The role of heparin, heparanase and heparan sulfates in hepcidin regulation
Asperti, M., Denardo, A., Gryzik, M., Arosio, P., & Poli, M. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.008 · Cited by 18
Susanah, S., Rakhmilla, L. E., Ghozali, M., Trisaputra, J. O., Moestopo, O., Sribudiani, Y., Idjradinata, P. S., & Maskoen, A. M. (2021) · BioMed Research International · doi:10.1155/2021/5560319 · Cited by 20
“These findings confirmed that GDF15 was not produced by proliferating erythroid precursors but rather by apoptotic erythroid cells, as in β-thalassemia [10].”
Backgroundvan Vuren, A. J., Sharfo, A., Grootendorst, S. T., van Straaten, S., Punt, A. M., Petersen, J., Fassi, D. E., van Solinge, W. W., Bartels, M., van Wijk, R., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000627 · Cited by 17
Pathogenic Mechanisms in Thalassemia II
Ganz, T., & Nemeth, E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.006 · Cited by 21
Self-citationModifying factors of theHFEhemochromatosis phenotype
Deugnier, Y., & Mosser, J. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.4.531 · Cited by 18
Singh, A. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00012-x · Cited by 19
Eisfeld, A., Westerman, M. E., Krahl, R., Leiblein, S., Liebert, U. G., Hehme, M., Teupser, D., Niederwieser, D. W., & Al‐Ali, H. K. (2011) · Advances in Hematology · doi:10.1155/2011/491058 · Cited by 18
“But other factors as overexpression of the growth and differentiation factor (GDF-15) which inhibits the production of hepcidin in the liver have been discussed as possible contributors to excess body iron in thalassemia [22].”
BackgroundThe use of hypotransferrinemic mice in studies of iron biology
Bu, J. T., & Bartnikas, T. B. (2015) · BioMetals · doi:10.1007/s10534-015-9833-0 · Cited by 18
“Identified by gene expression profiling of erythroblasts, Twsg1 and Gdf15 Biometals (2015) 28:473–480 477 both inhibit hepcidin expression in vitro (Tanno et al. 2007, 2009).”
Grootendorst, S. T., de Wilde, J. R. A., van Dooijeweert, B., van Vuren, A. J., van Solinge, W. W., Schutgens, R. E. G., van Wijk, R., & Bartels, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042204 · Cited by 18
“While GDF15 is not crucial during steady-state erythropoiesis, it plays a potential role in stress-erythropoiesis, as has primarily been demonstrated in mouse models [30,32,33].”
BackgroundIron and erythropoiesis: A mutual alliance
Silvestri, L., & Nai, A. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.002 · Cited by 19
Wang, S., Chen, C., Yu, L., Mueller, J. H., Rausch, V., & Mueller, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101378 · Cited by 17
The role of disrupted iron homeostasis in the development and progression of arthropathy
Karim, A., Bajbouj, K., Qaisar, R., Hall, A. C., & Hamad, M. A. (2022) · Journal of Orthopaedic Research® · doi:10.1002/jor.25323 · Cited by 17
Iron absorption and distribution in TNFΔARE/+ mice, a model of chronic inflammation
Schümann, K., Herbach, N., Kerling, C., Seifert, M., Fillebeen, C., Prysch, I., Jg, R., Weiß, G., & Pantopoulos, K. (2009) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2009.10.002 · Cited by 17
Przybyłowski, P., Wasilewski, G., Bachórzewska-Gajewska, H., Gołąbek, K., Dobrzycki, S., & Małyszko, J. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.09.040 · Cited by 16
Iron-deficiency anemia secondary to mutations in genes controlling hepcidin
Cau, M., Melis, M. A., Congiu, R., & Galanello, R. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.2 · Cited by 20
Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
Krijt, J., Fujikura, Y., Šefc, L., Vokurka, M., Hlobenová, T., & Necas, E. (2010) · PubMed · doi:10.33549/physiolres.931706 · Cited by 18
Myelofibrosis, JAK2 inhibitors and erythropoiesis
Vainchenker, W., & Favale, F. (2013) · Leukemia · doi:10.1038/leu.2013.72 · Cited by 18
Storti, F. (2008) · Cited by 16
Feldman, T. P., Ryan, Y., & Egan, E. S. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010844 · Cited by 15
“71 We also found altered expression of transcripts encoding ribosomal proteins, a hallmark of DBA.”
BackgroundTarchi, L., Maiolini, G., Villa, G., Rovero, P., Logu, F. D., Nassini, R., Garella, R., Sassoli, C., Ricca, V., Castellini, G., et al. (2025) · Current Molecular Medicine · doi:10.2174/0115665240327723241018073535 · Cited by 15
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.